PROCEPT BioRobotics PRCT Cash Flow Statement (2020-2026)

NASDAQ PRCT
$21.81 -0.10 (-0.46%)
At close: Aug 20, 2026 · 12:08 PM UTC
Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-17.94M-18.02M-19.64M-19.32M-39.54M-23.97M-77.96M-44.05M-30.04M-32.12M-41.54M-31.64M-35.05M-20.85M-24.74M-60.82M-60.75M-31.87M-31.64M-26.86M
Share-based Compensation (Quarter)
0.93M-2.30M1.55M2.68M18.44M0.19M3.72M5.10M5.33M4.98M6.26M7.99M8.51M9.09M10.11M12.16M14.49M10.84M13.07M14.53M
Gains from Investment Securities (Quarter)
-0.02M-0.04M
Asset Writedowns and Impairment (Quarter)
0.11M0.09M-0.03M0.23M0.19M0.58M-0.99M0.91M0.38M0.60M0.33M0.16M0.08M-0.35M0.20M0.43M
Cash from Operations (Quarter)
-12.75M-16.48M-18.23M-17.13M-19.85M-25.17M-35.93M-28.34M-18.94M-24.79M-32.29M-15.74M-18.80M-32.39M-16.98M-15.04M-6.63M-10.33M-38.13M-19.25M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.80M0.76M0.76M0.72M0.70M0.66M0.79M0.64M1.05M1.32M1.18M1.27M1.33M1.45M1.48M1.59M1.62M1.71M1.74M1.99M
Change in Working Capital
Change in Receivables (Quarter)
1.21M-1.89M2.53M3.90M1.95M2.43M5.37M12.53M1.45M13.75M7.71M2.83M10.59M14.83M-3.93M2.71M4.35M-2.23M13.32M11.63M
Change in Inventory (Quarter)
0.82M2.54M-0.52M1.20M8.82M5.75M10.14M3.29M-0.48M-3.19M1.49M2.79M7.16M5.80M6.28M4.79M-0.57M4.00M7.03M-0.20M
Change in Account Payables (Quarter)
0.24M-1.55M0.45M0.50M3.30M-0.28M2.23M0.01M-2.32M5.88M-2.31M0.34M5.19M-5.38M3.75M-2.25M-0.79M5.93M1.54M-2.85M
Change in Accured Expenses (Quarter)
-1.46M1.60M-1.89M2.32M0.89M5.65M0.35M-3.84M3.82M3.12M0.03M1.40M0.52M-1.81M-6.56M8.12M-1.35M-0.07M-4.69M1.96M
Other Working Capital Changes (Quarter)
-1.41M-0.18M0.48M-0.10M1.68M0.08M0.28M0.50M0.68M-0.51M1.04M2.00M0.40M-1.48M1.76M2.22M-1.17M-0.80M
Investing Activities
Capital Expenditures (Quarter)
-0.03M0.39M0.35M-0.08M1.51M1.76M5.34M5.37M5.78M-14.63M0.56M2.43M-2.96M0.32M1.39M3.25M2.87M1.85M2.91M2.95M
Cash from Investing Activities (Quarter)
-0.11M-0.33M-0.06M-0.22M-1.51M-0.87M-5.34M-5.37M-5.78M-8.71M-1.95M-1.04M-0.25M-1.17M-1.84M-2.80M-2.87M-1.85M-2.91M-2.95M
Financing Activities
Other financing activities (Quarter)
0.85M168.87M1.29M1.57M0.78M0.37M0.38M0.71M0.41M0.97M2.59M3.17M1.72M3.60M1.30M0.87M1.08M1.58M0.22M0.18M
Cash from Financing Activities (Quarter)
174.12M0.64M1.29M2.86M0.78M-1.32M0.38M2.43M162.12M2.87M2.59M5.30M1.72M170.53M1.30M4.38M1.08M4.44M0.22M4.50M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
-1.29M164.52M
Additional items
Exchange Rate Effect (Quarter)
-0.02M-0.01M-0.04M-0.04M-0.02M
Change in Cash (Quarter)
161.26M-16.16M-17.00M-14.48M-20.59M-27.36M-40.89M-31.28M137.40M-30.64M-31.65M-11.48M-17.33M136.96M-17.52M-13.49M-8.44M-7.78M-40.86M-17.73M
Free Cash Flow (Quarter)
-12.72M-16.87M-18.58M-17.05M-21.36M-26.93M-41.27M-33.71M-24.72M-10.16M-32.84M-18.17M-15.84M-32.71M-18.37M-18.29M-9.50M-12.18M-41.04M-22.20M
Net Cash Flow (Quarter)
161.26M-16.16M-17.00M-14.48M-20.59M-27.36M-40.89M-31.28M137.40M-30.64M-31.65M-11.48M-17.33M136.96M-17.52M-13.47M-8.43M-7.74M-40.82M-17.71M